Search Results 401-410 of 24191 for In situ

1. A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

   ... in Adult Participants With Previously Treated Non-Squamous Non-Small Cell ... * Adequately treated carcinoma in situ without current evidence of disease.

2. Phase 3 Study to Treat Patients with Soft Tissue Sarcomas - Mayo Clinic

   ... in situ, superficial bladder cancer or carcinoma in situ of the cervix unless documented free of cancer for ≥5 years. Laboratory values: Screening serum ...

3. An Open-label Study to Assess the Anti-Tumor Activity and Safety of REGN1979, an Anti-CD20 X Anti-CD3 Bispecific Antibody, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   ... in malignant lymphoma (Cheson, 2014) non-Hodgkin ... situ cervical carcinoma, or any other tumor that ... in the protocol or other uncontrolled infections

4. Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma - Mayo Clinic

   ... in-situ of the cervix. NOTE: if there is a history of prior malignancy, they must not be receiving other specific treatment for their cancer. Active central ...

5. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Exploratory Effectiveness of Nimacimab in Patients With Diabetic Gastroparesis - Mayo Clinic

   ... in situ (e.g., breast carcinoma, cervical cancer in situ) that have undergone potentially curative therapy are not excluded. Participants have a known ...

6. A Phase 2, Multicenter, Randomized Study of AP26113 - Mayo Clinic

   Have documented ALK rearrangement by a positive result from the Vysis® ALK Break-Apart fluorescence in situ hybridization (FISH) Probe Kit; or; Have ...

7. Breast Education through Simulation Training (BEST): Post-Mastectomy Wound and Drain Care Patient Education - Mayo Clinic

   Adult post breast or axillary surgery patients with 2 or more JP drains in situ; Adult primary wound and drain care provider, if different from the patient ...

8. Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis - Mayo Clinic

   ... in situ cervical cancer, adequately treated Stage I or II cancer from which the patient is currently in complete remission, or any other cancer from which ...

9. A Study Of Intravesical BCG In Combination With ALT-803 In Patients With Non-Muscle Invasive Bladder Cancer - Mayo Clinic

   ... in situ cervical cancer, adequately treated stage 1 or 2 cancer from which the patient is currently in complete remission, or stable prostate cancer (under ...

10. Mavacamten in Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction Therapy - Mayo Clinic

    Participated in a clinical trial in which the subject received any ... in situ or breast ductal carcinoma in situ may be included in the study; ...